RETIA MEDICAL, LLC

Retia Medical Announces Bernd Saugel has Joined the Clinical Advisory Board

Retrieved on: 
Tuesday, June 1, 2021
Medical specialties, Intensive care medicine, Medicine, Cardiac output, Cardiovascular physiology, Monitoring, Branches of biology

VALHALLA, N.Y., June 01, 2021 (GLOBE NEWSWIRE) -- Retia Medical, an innovator in hemodynamic monitoring that helps clinicians guide care to prevent complications from high-risk surgeries such as heart attacks, strokes, and acute kidney injuries, today announced that Bernd Saugel, MD, EDIC joins other distinguished clinicians on Retia Medicals Clinical Advisory Board.

Key Points: 
  • VALHALLA, N.Y., June 01, 2021 (GLOBE NEWSWIRE) -- Retia Medical, an innovator in hemodynamic monitoring that helps clinicians guide care to prevent complications from high-risk surgeries such as heart attacks, strokes, and acute kidney injuries, today announced that Bernd Saugel, MD, EDIC joins other distinguished clinicians on Retia Medicals Clinical Advisory Board.
  • We are delighted to welcome Dr. Saugel to our Clinical Advisory Board, said Marc Zemel, S.M., M.B.A., co-founder and Chief Executive Officer of Retia Medical.
  • Retia Medicals Argos Cardiac Output Monitor, with its Multi-Beat Analysis (MBA) algorithm, eliminates a critical problem with older cardiac output technologies.
  • Retia Medical is proud to positively impact patient care in the U.S. and internationally as more hospitals continue to incorporate the Argos Cardiac Output Monitor into their standard of care.

UMC Health System Implements Retia Medical’s Argos Cardiac Output Monitors Across Multiple ICUs

Retrieved on: 
Tuesday, March 16, 2021
Cardiac output, Cardiovascular physiology, Intensive care medicine

VALHALLA, N.Y., March 16, 2021 (GLOBE NEWSWIRE) -- Retia Medical announced today the successful installation of its Argos Cardiac Output Monitor within all five of the ICU facilities at UMC Health System in Lubbock, Texas.

Key Points: 
  • VALHALLA, N.Y., March 16, 2021 (GLOBE NEWSWIRE) -- Retia Medical announced today the successful installation of its Argos Cardiac Output Monitor within all five of the ICU facilities at UMC Health System in Lubbock, Texas.
  • UMC has installed Argos Cardiac Output Monitors in its Timothy J. Harnar Regional Burn Center, Medical ICU, Surgical ICU, Neuro ICU and Cardiac ICU.
  • We look forward to supporting the Argos Cardiac Output Monitors to assess the cardiovascular status of critically ill patients across the UMC ICU facilities.
  • Retia Medicals Argos Cardiac Output Monitor, with its Multi-Beat Analysis (MBA) algorithm, eliminates a critical problem with older cardiac output technologies.

New Study Validates Retia Medical’s MBA™ Algorithm Accuracy in Tracking Cardiac Output Changes Caused by Fluid and Drug Interventions in High-Risk Surgical Patients

Retrieved on: 
Friday, March 12, 2021
Cardiac output, Cardiovascular physiology

The results showed that the cardiac output changes measured by the MBA algorithm agreed with the reference method, transesophageal Doppler (TED), 93% of the time (as determined using the concordance statistic).

Key Points: 
  • The results showed that the cardiac output changes measured by the MBA algorithm agreed with the reference method, transesophageal Doppler (TED), 93% of the time (as determined using the concordance statistic).
  • Significantly, the authors found that the MBA method was able to track changes caused by both fluid and vasopressor challenges.
  • The consistent accuracy of the MBA algorithm is a significant advantage of the Argos Cardiac Output Monitor.
  • Retia Medicals Argos Cardiac Output Monitor enables individualized, data-driven care to improve outcomes and lower costs for high-risk surgical and critically ill patients.

Argos Cardiac Output Monitor Earns CE Mark Approval

Retrieved on: 
Thursday, January 21, 2021
Medical specialties, Branches of biology, Medicine, Intensive care medicine, Cardiac output, Cardiovascular physiology, Monitoring, Heart, Zemel

VALHALLA, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Retia Medical, a leading provider of minimally-invasive hemodynamic monitoring technology today announced it received CE (Conformit Europenne) Mark approval for its Argos Cardiac Output Monitor.

Key Points: 
  • VALHALLA, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Retia Medical, a leading provider of minimally-invasive hemodynamic monitoring technology today announced it received CE (Conformit Europenne) Mark approval for its Argos Cardiac Output Monitor.
  • Retia's CEO Marc Zemel stated, "Obtaining the CE mark for the Argos Cardiac Output Monitor is a significant corporate milestone and a testament to the quality of the Argos Monitor and to Retias compliance with all applicable European health, safety, performance and environmental requirements."
  • Retias Multi-Beat Analysis (MBA) algorithm offers consistently accurate cardiac output measurements by analyzing multiple heartbeats for each cardiac output calculation.
  • A simple setup requiring only one interconnect cable to attach the Argos to the existing bedside monitor making it the easiest-to-use cardiac output monitor on the market.

University Hospitals Cleveland Medical Center Implements Retia Medical’s Argos Cardiac Output Monitors

Retrieved on: 
Wednesday, January 13, 2021
Anesthesiology, Cardiac output

VALHALLA, N.Y., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Retia Medical today announced successful installation of its Argos Cardiac Output Monitor within the cardiac anesthesiology ORs at University Hospitals Cleveland Medical Center.

Key Points: 
  • VALHALLA, N.Y., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Retia Medical today announced successful installation of its Argos Cardiac Output Monitor within the cardiac anesthesiology ORs at University Hospitals Cleveland Medical Center.
  • The Argos monitor supports accurate, data-driven patient care and decision making by our critical care teams, says Brian Fitzsimons, MD, Director of Anesthesia, Harrington Heart and Vascular Institute, Chief, Section of Cardiac Anesthesiology for University Hospitals Cleveland Medical Center.
  • Retia Medicals Argos Monitor, with its Multi-Beat Analysis (MBA) algorithm, eliminates a critical problem with older cardiac output technologies.
  • Additionally, the Argos system is unique in its class by not requiring costly disposables to monitor each patient, and is available at a low, fixed capital cost.

Capsule and Retia Medical Collaborate on Argos Cardiac Monitor to Streamline Device Interoperability, Protect Patient Safety

Retrieved on: 
Tuesday, January 5, 2021
Cardiac electrophysiology, Cardiovascular physiology, Cardiac output, Cardiac monitoring, Argos, Argos, DDI, Spacecraft

and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule Technologies new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today.

Key Points: 
  • and VALHALLA, N.Y., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Retia Medical is the first company to utilize Capsule Technologies new Device Driver Interface (DDI) development strategy to integrate its Argos Cardiac Monitor, the companies announced today.
  • Medical devices, such as Retia Medicals Argos Cardiac Monitor, are indispensable for delivering safe and high-quality patient care, said John McHutcheon, Vice President of Operations of Capsule Technologies.
  • By leveraging the new DDI development strategy, Retia Medical expedited the integration of its updated Argos Cardiac Monitor, saving engineering time and improving customer satisfaction.
  • Retia Medicals Argos Monitor, with its Multi-Beat Analysis (MBA) algorithm, eliminates a critical problem with older cardiac output technologies.

Retia Medical’s Innovative Argos Cardiac Output Monitors Now Used at World-Renowned Academic Medical Center

Retrieved on: 
Monday, November 2, 2020
Medical specialties, Medicine, Intensive care medicine, Clinical medicine, Cardiac output, Cardiovascular physiology, Resuscitation, Monitoring

VALHALLA, N.Y., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Retia Medical is pleased to announce the successful installation of its Argos Cardiac Output monitors within the Duke University Health System.

Key Points: 
  • VALHALLA, N.Y., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Retia Medical is pleased to announce the successful installation of its Argos Cardiac Output monitors within the Duke University Health System.
  • This provides access to Retia Medicals industry-leading hemodynamic monitoring technology to help guide clinical decisions during volume resuscitation and vasoactive therapy for critically ill patients.
  • Marc Zemel, co-Founder and CEO of Retia Medical said, As a Duke alumnus, I appreciate Dukes reputation of being a pioneering institution.
  • Retia Medicals Argos Monitor, with its Multi-Beat Analysis (MBA) algorithm, eliminates a critical problem with older cardiac output technologies.

Retia Medical’s Industry-Leading Argos Cardiac Output Monitors Now Used at The Johns Hopkins Hospital

Retrieved on: 
Tuesday, September 15, 2020
Intensive care medicine, Monitoring

VALHALLA, N.Y., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Retia Medical is pleased to announce the successful installation of its Argos Cardiac Output monitor at The Johns Hopkins Hospital.

Key Points: 
  • VALHALLA, N.Y., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Retia Medical is pleased to announce the successful installation of its Argos Cardiac Output monitor at The Johns Hopkins Hospital.
  • This gives Johns Hopkins physicians access to Retia Medicals industry-leading hemodynamic monitoring technology to help optimize cardiac function during volume and pressor resuscitation of critically ill patients.
  • We look forward to supporting their world-class care teams use of the Argos Monitor to assess the cardiovascular status of their critically ill patients.
  • Retia Medical is proud to positively impact patient care in the US and internationally as more hospitals continue incorporating the Argos Monitor into their standards of care.

Retia Medical Receives Purchase Orders From Three of the Top Five Hospitals in the United States

Retrieved on: 
Wednesday, October 30, 2019
Intensive care unit, Intensive care medicine

The hospitals, each rated by US News and World Report, are high performing in a broad range of key adult procedures and specialties.

Key Points: 
  • The hospitals, each rated by US News and World Report, are high performing in a broad range of key adult procedures and specialties.
  • The Argos Monitors will be installed in multiple high-risk operating rooms and intensive care units in each hospital.
  • For each hospital, their competitive bid processes involved extensive clinical review and technology value analysis by their internal committees.
  • Since being introduced in the U.S. market, numerous hospital systems have evaluated and adopted the Argos in their ORs and ICUs.

RETIA MEDICAL Announces Two Publications of Independent Validation Studies of its Argos Cardiac Output Monitor in off-pump coronary artery bypass surgical (OR) patients and high-risk post-cardiac surgical patients in the ICU

Retrieved on: 
Wednesday, September 4, 2019
Medical specialties, Medicine, Clinical medicine, Cardiac surgery, Off-pump coronary artery bypass, Coronary artery bypass surgery, Monitoring, Cardiac output, Intensive care unit, Intensive care medicine

VALHALLA, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Retia Medical, LLC announced today the recent publications of two independent validation studies which confirmed the accuracy of the minimally invasive Argos Hemodynamic Monitor for monitoring cardiac output in off-pump cardiac bypass graft (OPCAB) patients during their OR procedures and recovery in the CTICU.

Key Points: 
  • VALHALLA, N.Y., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Retia Medical, LLC announced today the recent publications of two independent validation studies which confirmed the accuracy of the minimally invasive Argos Hemodynamic Monitor for monitoring cardiac output in off-pump cardiac bypass graft (OPCAB) patients during their OR procedures and recovery in the CTICU.
  • In two studies led by Bernd Saugel, MD from the University Medical Center Hamburg-Eppendorf in Hamburg, Germany, clinicians compared 572 paired (before/after intervention) CO measurements of a total of 58 OPCAB surgical patients and 167 paired (before/after intervention) CO measurements of 31 Intensive Care Unit patients.
  • We are grateful to have had the opportunity to provide the Argos monitor to Dr. Saugel and his team, who led an especially rigorous test of the performance of our monitor.
  • Retia Medical designed the Argos Cardiac Output (CO) Monitor to provide members of the Critical Care team in the operating room and intensive care unit with a more accurate, intuitive and affordable hemodynamic monitor that supports confident, data-based patient care decision making.